<code id='6806AEE8A6'></code><style id='6806AEE8A6'></style>
    • <acronym id='6806AEE8A6'></acronym>
      <center id='6806AEE8A6'><center id='6806AEE8A6'><tfoot id='6806AEE8A6'></tfoot></center><abbr id='6806AEE8A6'><dir id='6806AEE8A6'><tfoot id='6806AEE8A6'></tfoot><noframes id='6806AEE8A6'>

    • <optgroup id='6806AEE8A6'><strike id='6806AEE8A6'><sup id='6806AEE8A6'></sup></strike><code id='6806AEE8A6'></code></optgroup>
        1. <b id='6806AEE8A6'><label id='6806AEE8A6'><select id='6806AEE8A6'><dt id='6806AEE8A6'><span id='6806AEE8A6'></span></dt></select></label></b><u id='6806AEE8A6'></u>
          <i id='6806AEE8A6'><strike id='6806AEE8A6'><tt id='6806AEE8A6'><pre id='6806AEE8A6'></pre></tt></strike></i>

          hotspot

          hotspot

          author:comprehensive    Page View:42296

          What does Covid-19 have in store for the winter? When are good data not good enough? And how many would-be Wegovys are there?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.

          advertisement

          For more on what we cover, here’s the latest on booster shots; here’s more on Covid-19 in 2023; here’s the news on Alnylam Pharmaceuticals; here’s more on 2Seventy Bio; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          focus

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Latigo launches with $135 million for Vertex
          Latigo launches with $135 million for Vertex

          DesmondPadhi,PharmD,interimCEO,Latigo(center),withLatigoboardchairNancyStagliano(left)andWestlakeVil

          read more
          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more

          CMS got Medicare Advantage quality rating wrong, judge rules

          AdobeThefederalgovernmentinappropriatelyloweredthe2024MedicareAdvantagestarratingsofSCANHealthPlan,w